FDA Approves Vemurafenib for Treatment of Metastatic Melanoma.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 10, p. 906
- Publication type:
- Article
Works matching IS 08909091 AND DT 2011 AND VI 25 AND IP 10
Results: 20
1
2
FDA Approves Brentuximab Vedotin for Hodgkin Lymphoma and Systemic Anaplastic Large-Cell Lymphoma.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 10, p. 904
- Publication type:
- Article
3
Local Recurrence Risk Factors in Women Treated With BCT for Early-Stage Breast Cancer.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 10, p. 895
- By:
- Publication type:
- Article
4
Ginkgo (Ginkgo biloba).
- Published in:
- Oncology (08909091), 2011, v. 25, n. 10, p. 971
- By:
- Publication type:
- Article
5
Bladder Cancer: Imperatives for Personalized Medicine.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 10, p. 951
- By:
- Publication type:
- Article
6
ONCOLOGY PERSPECTIVES: Humor and Oncology.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 10, p. 970
- By:
- Publication type:
- Article
7
HEMATOLOGY LETTERS FROM OMAHA: Revisiting the Role of Interferon Alfa-2 in the Treatment of Early Myelofibrosis.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 10, p. 970
- By:
- Publication type:
- Article
8
Bladder Cancer: Time for a Rethink?
- Published in:
- Oncology (08909091), 2011, v. 25, n. 10, p. 965
- By:
- Publication type:
- Article
9
Bladder Cancer: A Condition Worthy of Clinical Investigation.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 10, p. 960
- By:
- Publication type:
- Article
10
Controversies in the Management of Advanced Ovarian Cancer.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 10, p. 934
- By:
- Publication type:
- Article
11
What Are Safe Margins of Resection for Invasive and In Situ Breast Cancer?
- Published in:
- Oncology (08909091), 2011, v. 25, n. 10, p. 890
- By:
- Publication type:
- Article
12
Joseph Sparano on Gene Expression Assays for Breast Cancer.
- Published in:
- 2011
- Publication type:
- Interview
13
Is Neoadjuvant Chemotherapy in Ovarian Cancer an Excuse for Insufficient Surgery?
- Published in:
- Oncology (08909091), 2011, v. 25, n. 10, p. 940
- By:
- Publication type:
- Article
14
Margin Status Following Partial Mastectomy: One Size Does Not Fit All!
- Published in:
- Oncology (08909091), 2011, v. 25, n. 10, p. 899
- By:
- Publication type:
- Article
15
Cytoreductive Surgery for Advanced Ovarian Cancer: Quo Vadis?
- Published in:
- Oncology (08909091), 2011, v. 25, n. 10, p. 928
- By:
- Publication type:
- Article
16
Cancer-Related TTP and Considerations of Plasma Exchange.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 10, p. 924
- By:
- Publication type:
- Article
17
Consider Thrombotic Microangiopathy in Pediatric and Hematopoietic Stem Cell Transplant Patients.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 10, p. 920
- By:
- Publication type:
- Article
18
Systemic Malignancies as a Cause of Unexpected Microangiopathic Hemolytic Anemia and Thrombocytopenia.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 10, p. 908
- By:
- Publication type:
- Article
19
Test Your Image IQ.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 10, p. 887
- Publication type:
- Article
20
Tools for Measuring and Improving the Quality of Oncology Care: The Quality Oncology Practice Initiative (QOPI®) and the QOPI Certification Program.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 10, p. 880
- By:
- Publication type:
- Article